AUS
NZ
UK
CA
USA
IND
Healthcare
Cogstate Limited Sees Notable Increase in Share Price Following Interim Results
February 22, 2025 11:37 AM AEDT| By Team Kalkine MediaHighlights:,Cogstate Limited's share price experienced a significant rise following interim financial results.,Revenue exceeded forecasts, leading to adjustments in earnings expectations.,Growth projections indicate a more moderate expansion compared...
Ecofibre Announces Earnings for the First Half of 2025
February 22, 2025 11:33 AM AEDT| By Team Kalkine MediaHighlights:,Revenue saw a slight decline from the previous year.,Net loss improved significantly over the period.,Share price experienced a recent downturn.,Ecofibre Limited (ASX:EOF) operates within the diversified industrials sector and has shared...
Dr. Boreham's Crucible: This Biotech Aiming to Address MSA Aspires to Be 'Distinctive'
February 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Alterity Therapeutics is progressing with clinical trials focused on addressing Multiple System Atrophy (MSA), a complex neurological disorder.,A successful funding initiative secured resources for ongoing research and clinical developmen...
Is Neurizon Therapeutics Facing Financial Pressure Amid Rising Cash Burn?
February 21, 2025 07:34 PM AEDT| By Team Kalkine MediaHighlights,Neurizon Therapeutics (ASX:NUZ) faces challenges due to increasing cash burn, affecting financial stability.,The company holds cash reserves but operates with a limited runway, requiring careful management.,Funding options may be explored,...
Can Steady Performance Sustain Future Growth in Healthcare?
February 21, 2025 07:30 PM AEDT| By Team Kalkine MediaHighlights:,Revenue and earnings align with market expectations.,Share price experienced a modest decline following the report release.,Growth trends remain consistent with the broader healthcare sector.,Operating within the healthcare services indus...
How Does Cosette's Acquisition of Mayne Pharma Reflect Current Market Dynamics in Australia?
February 21, 2025 06:38 PM AEDT| By Team Kalkine MediaHeadlines,• Australian shares display a downturn while technology entities enjoy a surge.,• A significant transaction sees Cosette acquiring Mayne Pharma in a deal valued at six hundred seventy‐two million Australian dollars.,• The arrangement unders...
What Are the Details Behind Opthea Limited's New ASX Quotation?
February 21, 2025 06:36 PM AEDT| By Team Kalkine MediaHeadlines,Update on the application for a new securities quotation on the Australian exchange,Issuance derived from the exercise of options and conversion of convertible instruments,Corporate structural adjustments unfolding within the healthcare and...
Telix Pharmaceuticals' (ASX:TLX) Shares Surge on Strong Full-Year Profit Growth
February 21, 2025 01:56 PM AEDT| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals (TLX) posts a tenfold increase in full-year profit.,The stock climbs over 13% following the announcement.,Shares have gained more than 170% over the past year.,Telix Pharmaceuticals (ASX:TLX) experienced a significant...
Mayne Pharma Backs $672 Million Takeover Offer from Cosette Pharma
February 21, 2025 01:51 PM AEDT| By Team Kalkine MediaHighlights,Mayne Pharma (,ASX:MYX,) receives a $7.40 per share acquisition offer from Cosette Pharma.,The deal,represents,a 37% premium to Mayne Pharma’s last closing price.,The acquisition expands Cosette Pharma’s portfolio and global presence in wo...
Telix Pharmaceuticals: Revenue Up 56%, Profit Jumps 860%, and More Growth Expected in FY 2025
February 21, 2025 11:13 AM AEDT| By Team Kalkine MediaKey Highlights:,Record High Share Price:,Telix shares hit,$30.00,, up,13%,on Friday morning.,Revenue Growth:,Revenue surged,56% to $783.2 million,, beating expectations.,Profit Explosion:,Profit after tax,soared 860% to $49.9 million,.,Strong FY 2025...
ASX Healthcare Sector: Market Resilience and Key Developments
February 21, 2025 11:00 AM AEDT| By Team Kalkine MediaASX Healthcare Sector: Market Resilience and Key Developments
Healius Navigates Turnaround Plan with Pathology Growth Amid Short-Term Challenges (ASX:HLS)
February 20, 2025 02:40 PM AEDT| By Team Kalkine MediaHighlights,Reports,$12.8 million net loss,amid business,restructuring,.,Revenue jumps 10%,to $933.9 million, with strong pathology growth.,Plans,special dividend,after debt refinancing.,Healius (ASX:HLS), Australia's second-largest pathology group, h...
Is Vitura Health Overlooked in Australia’s Pharmaceuticals Market?
February 20, 2025 11:30 AM AEDT| By Team Kalkine MediaHighlights:,Shares have rebounded in recent weeks despite a steep decline over the previous year.,The price‐to‐sales metric remains considerably lower than that of many industry peers.,Revenue expansion has been moderate relative to the broader perfo...
Neurotech International Gains Key Regulatory Support for Rett Syndrome Drug
February 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,(ASX:NTI) secures a positive opinion from the European Medicines Agency for NTI164’s Orphan Medicinal Product Designation.,The US FDA granted orphan drug status to NTI164 in late 2024, signaling progress for the treatment’s potential appro...
Cochlear's (ASX:COH) Market Moves: Why This Healthcare Stock is on the Radar
February 20, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Cochlear (COH) stock has seen a 5.3% dip in 2025, drawing investor attention.,The healthcare sector remains a stable revenue generator, even during economic downturns.,Cochlear’s long-term growth outlook benefits from rising global healthc...
CardieX Limited Navigating the Path to Profitability
February 19, 2025 03:33 PM AEDT| By Team Kalkine MediaCardieX Limited Navigating the Path to Profitability
Fast-Track Approval Boosts Clarity Pharmaceuticals' Prostate Cancer Breakthrough
February 19, 2025 03:08 PM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals secures fast-track approval for its prostate cancer drug.,The FDA’s decision accelerates development and market entry.,Cu-SAR-,bisPSMA,aims to enhance treatment options for advanced prostate cancer.,Clarity Pharmace...
Imagion Biosystems Moves Forward with FDA Application for MagSense HER2 Imaging Agent
February 19, 2025 02:09 PM AEDT| By Team Kalkine MediaHighlights,Imagion,Biosystems (IBX) progresses with FDA application for its,MagSense,HER2 imaging agent.,Phase 2 study aims to,optimize,dose and imaging protocol for improved diagnostic accuracy.,Recent capital funding of $3 million supports the next...
Will Clarity Pharmaceuticals' Imaging Agent Change Prostate Cancer Detection?
February 19, 2025 01:31 PM AEDT| By Team Kalkine MediaHighlights,FDA fast-track designation for prostate cancer imaging agent.,Innovation in dual-targeted bisPSMA technology developed in Australian laboratories.,Elevated market activity observed in the Australian biotech sector.,The biotechnology field...
Why Cyclopharm's (ASX:CYC) Cash Burn Isn't a Major Concern for Us
February 19, 2025 11:32 AM AEDT| By Team Kalkine MediaHighlights,Cyclopharm's cash reserves suggest a stable runway for growth.,Analyst forecasts indicate potential for cashflow breakeven soon.,Market capitalization analysis hints at feasible fundraising strategies.,Investors often find that even in cha...
Advertise your brand on Kalkine Media